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Abstract
Smoking during pregnancy is a plausible risk factor for childhood cancer, yet previous studies 
have yielded conflicting results, and few prospective studies have been published.
Data on maternal smoking were obtained from California birth certificates. We linked California 
birth certificates (births 2007–2011) with California Cancer Registry records for childhood cancer 
cases (diagnosed January 2007 – September 2013) that were ages 5 or younger at diagnosis (N 
cases=2,021). Controls (N=40,356) were frequency-matched by birth year and randomly selected 
from birth certificate records. We used unconditional logistic regression to obtain odds ratios (OR) 
and 95% confidence intervals (CI) to assess the association between smoking during pregnancy 
and childhood cancer.
We observed positive associations for gliomas (OR=1.8, 95% CI: 1.0–3.4) and retinoblastoma 
(OR=3.0, 95% CI: 1.4–6.6), particularly bilateral retinoblastoma (OR=9.4, 95% CI 3.6–24.7) with 
maternal smoking in pregnancy.
Maternal smoking during pregnancy may be a risk factor for retinoblastoma and certain types of 
childhood brain tumors.
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Introduction
Smoking is the leading cause of cancer worldwide, and the constituents of tobacco rapidly 
cross the placenta and are found in cord blood and fetal tissues.
1
 Most of the epidemiologic 
literature on parental smoking and childhood cancer is comprised of retrospective case-
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control studies which collected data via parental interview. These studies may be subject to 
selective participation, recall biases, or a limited willingness to disclose smoking status in 
pregnancy to research interviewers. There remains a need for prospective population-based 
studies.
Materials and Methods
In 2007, California began collecting maternal smoking information on the birth certificate. 
Data on maternal smoking, demographics, and pregnancy and birth-related factors are 
abstracted by hospital clerks from the medical record, reported by the mother’s physician or 
midwife, or self-reported by mothers.
We linked California birth certificates (births 2007–2011) with California Cancer Registry 
records for childhood cancer cases (diagnosed January 2007–September 2013) that were 
ages 5 or younger at diagnosis. Controls were frequency-matched by year of birth. Detailed 
methods have been previously published.
2
 We estimated adjusted odds ratios among cancer 
types with ≥5 exposed cases only, and additionally estimated risk for hepatoblastoma 
because parental smoking was classified as a cause of hepatoblastoma by the International 
Agency for Research on Cancer.
3
 Cancer types were categorized using International 
Classification of Childhood Cancer (ICCC) codes, however in order to compare results to 
other studies, we additionally examined risk among all gliomas, high-grade, and low-grade 
gliomas, defining these subtypes using International Classification of Diseases for Oncology 
(ICD-O-3) codes as categorized by the Central Brain Tumor Registry of the United States 
(CBTRUS).
4
 Thus glioma cases overlap with astrocytoma cases. Odds ratios (OR) and 95% 
confidence intervals were ascertained using unconditional logistic regression, with 
adjustment for the child’s birth year (matching variable), the race/ethnicity of the mother 
(White non-Hispanic vs. all others), and maternal years of education. Additional adjustment 
for the number of prenatal care visits and the source of payment for prenatal care (a 
socioeconomic indicator, as described previously
2
) did not change results and were left out 
of final models.
Data were collected on smoking status in the three months pre-pregnancy and within each 
trimester, however smoking status was strongly correlated across trimesters (r~0.77–0.91). 
Thus our analysis examined ever smoking during any point in pregnancy in the main results.
Results
Compared to mothers of cases, a slightly higher proportion of control mothers smoked in the 
3 months before pregnancy (3.8% vs. 3.2%). During pregnancy, however, smoking was more 
common among case mothers (1st trimester, 2.7%; 2nd trimester, 2.1%; 3rd trimester, 1.8%) 
than among control mothers (1st trimester, 2.5%; 2nd trimester, 1.8%; 3rd trimester, 1.7%). 
Hence, of all the mothers who smoked prior to pregnancy, 16% of case mothers and 34% of 
control mothers quit smoking during the 1st trimester.
We observed positive associations for glial tumors and retinoblastoma with maternal 
smoking in pregnancy, with a particularly elevated risk estimate for bilateral retinoblastoma 
(Table 1). With regards to central nervous system tumor subtypes, gliomas (OR=1.8, 95% 
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confidence interval 1.0–3.4) were elevated. We also observed an elevated risk estimate for 
astrocytomas, which made up 123 of the 194 gliomas (adjusted OR=2.0, 95% confidence 
interval 0.9, 4.2).
We additionally examined the risk from smoking by trimester of pregnancy for gliomas and 
retinoblastomas. The adjusted estimates for gliomas were fairly similar across trimesters (1st 
trimester, OR=1.7; 2nd trimester, OR=1.6; 3rd trimester, OR=1.5) whereas adjusted estimates 
for retinoblastoma appeared to steadily increase with each subsequent trimester (1st 
trimester, OR=3.1; 2nd trimester, OR=4.5; 3rd trimester, OR=5.0).
The prevalence of smoking was high among mothers of children with both low grade 
gliomas (4/53 cases, 7.6%) and high-grade gliomas (1/14 cases, 7.1%). Other cancer types 
were generally null excepting leukemia where point estimates were below unity, with wide 
confidence intervals.
Discussion
In this records-based prospective study, we observed increased risk for two major types of 
childhood cancers. Among all cancers, smoking quit rates during the 1st trimester were 
higher among control mothers than among case mothers, and the prevalence of smoking in 
pregnancy was particularly high for bilateral retinoblastoma (15.4%). Children with bilateral 
retinoblastoma carry a germline mutation in one allele of a retinal progenitor cell, due to 
RB1 inheritance from a parent, de novo mutation in parental germline cells, or due to a 
mutation that occurs during very early embryonic development; these children lose the 
second allele somatically during the pregnancy. Only a small number of studies have 
reported on maternal smoking and retinoblastoma, but several have reported increased effect 
estimates.
5–7 Of these, one study reported an increased risk for maternal smoking in the first 
trimester and bilateral retinoblastoma (OR=3.7),
7
 and another study an increase with 
sporadic heritable disease (OR=2.0), which typically presents as bilateral;
5
 the third study 
did not stratify by laterality. Our findings for astrocytoma support those seen in another 
prospective investigation.
8
The decreased risk we observed with acute lymphoblastic leukemia (ALL) has been reported 
in other prospective studies
6, 9–11 and may be due to competing risks such as miscarriage or 
the development of fatal birth defects.
12
 If so, our results for all cancer types might be 
underestimated. Further, this would explain the seemingly counterintuitive results seen in 
studies which have examined leukemia risk according to cigarettes per day. Several of these 
studies have reported an higher risk estimate for ALL with light smoking (e.g. <6 or <10 
cigarettes per day) but then decreasing point estimates with heavier smoking,
13–18 with 
reported effect estimates as low as 0.26 for maternal smoking of more than 30 cigarettes per 
day.
16
Many women attempt to quit smoking during pregnancy, and the smoking patterns exhibited 
often involve attempts to cut down, quit, followed by relapsing and attempting to quit again. 
Overall, between 20–50% of female smokers attempt to quit or reduce their smoking during 
pregnancy;
19
 of these women, roughly half quit successfully, and the other half change their 
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smoking intensity multiple times.
20
 As such, the complex pattern of smoking during 
pregnancy could not be captured with our study design. Nondifferential misclassification 
may also be expected due to errors in recall or due to poor willingness to disclose smoking 
to medical providers, due to the stigma attached to smoking during pregnancy in the United 
States. Thus there are concerns for the accuracy of medical-record abstracted smoking status 
in our data. Validation studies of maternal smoking status on birth certificates suggest that 
smoking has moderate sensitivity (74–89%) but high specificity (99%),
21, 22 which should 
be expected to slightly attenuate effect estimates.
California residents smoke less than residents of other US States, with current smoking 
reported by 17% of adult males and 10% of adult females in 2011.
23
 The prevalence of 
smoking that we observed on birth certificates is lower than that reported among pregnant 
California women in a 2003 survey (8.7%)
24
 although adult smoking rates may dropped 
since that survey was published, as they have done nationally.
25
 In addition, the proportion 
of births from Hispanic and Asian/Pacific Islander women have risen in California across the 
last several decades, and those women are less likely to smoke in pregnancy than women of 
other ethnic groups (3% of Hispanic women and 2% of Asian/Pacific Islander women smoke 
in pregnancy, as compared to 14% of White non-Hispanics).
26
 In the present study, 52% of 
mothers were Hispanic and 10% were Asian/Pacific Islander.
Interpretation of results and comparison to other studies should be considered in light of the 
younger age of the children in our study (<6 years at diagnosis). Exposures during 
pregnancy may be most relevant for childhood cancers which are diagnosed at younger ages. 
Further, variation in histologic subtype by age for central nervous system and germ cell 
cancers, among other cancer types, should limit generalizability to older cohorts.
4
 In 
contrast, as the embryonal tumors (neuroblastoma, Wilms tumor, retinoblastoma) occur 
primarily in younger childhood, most cases diagnosed during the study period would have 
been included in our analysis.
If a child’s cancer is diagnosed during pregnancy or at birth, medical personnel might be 
more vigilant in reporting smoking on the birth certificate. However, this was unlikely to 
have biased our results because by California law, births must be registered with the State 
within 10 days of the child’s birth. In our data, there were no cases of glioma, astrocytoma, 
or retinoblastoma diagnosed prior to two weeks of age whose mothers were smokers. A 
limitation of our study design was that it did not allow exclusion of cases with a family 
history of disease. We also lacked covariate information on possible confounders such as 
maternal alcohol consumption, occupational pesticide exposure, and paternal smoking, 
which could introduce residual confounding.
As we were able to include only 5 years of California births, the sample size of our study 
was small and data should be viewed as preliminary. Nonetheless our findings corroborate 
other prospective studies. Further research might ascertain smoking by cotinine assay, and it 
may be insightful for future meta-analyses on maternal smoking and childhood cancer to 
compare findings between prospective and retrospective studies.
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This article is one of the few prospective, population-based studies of maternal pregnancy 
smoking and childhood cancer, with smoking status collected by medical record review. 
We report increased risk of retinoblastoma and some childhood brain tumors with 
maternal smoking during pregnancy.
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